Percy Schröttner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Percy Schröttner has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Boyke Bunk
Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures GmbH
11 shared publicationsFlorian Gunzer
Medical Microbiology and Virology, University Hospital Carl Gustav Carus, Dresden, Germany
9 shared publicationsWolfram W. Rudolph
Institut für Virologie, TU Dresden, Fetscherstrasse 74, 01307, Dresden, Germany
7 shared publicationsThomas Riedel
Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, Brunswick, Germany
5 shared publicationsAnna Kopf
Clinic for Cardiology, Sana Heart Center, Cottbus, Germany
3 shared publicationsIsabel Schober
Leibniz-Institut DSMZ-Deutsche Sammlung für Mikroorganismen und Zellkulturen GmbH, Inhoffenstr. 7 B, 38124, Braunschweig, Germany
2 shared publications
Latest Publications
- Open Access
- 5 October 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1901541
Comparison of three routine methods for the identification of Kerstersia gyiorum from routine diagnostics and review of the literature
Introduction: Since its first description in 2003, clinical case reports have repeatedly documented that the bacterial species Kerstersia gyiorum is a human pathogen. K. gyiorum has been described in the context of wound and middle ear infections, has been found in urine samples, and has even been recognized as a causative agent of septicemia. However, the pathogenic potential of K. gyiorum cannot be clearly determined due to the current lack of information about this species. To reveal the clinical significance of K. gyiorum , it is therefore essential to first create a clearly defined reference collection of isolates obtained from routine clinical diagnostics. Methods: The aim of this study is to determine the most appropriate method for identifying K. gyiorum in routine diagnostics. To this end, three widely used routine methods (VITEK 2, MALDI-TOF MS, and 16S rRNA gene sequencing) were employed, and the accuracy of their results for K. gyiorum identification was compared. To ensure accurate species identification, dDDH (an NGS-based identification strategy) was used as the reference method. Furthermore, this manuscript provides an overview of all cases reported in the literature to date and discusses the accuracy of the identification results reported in these studies. In addition, genomic studies (pangenome and ANI matrix) were conducted using in silico analyses to investigate the clonal relationships among the isolates. Results: The results show that MALDI-TOF MS is best suited for identifying K. gyiorum in routine diagnostics. However, in contrast to most publications, 16S rRNA gene sequencing was not suitable, as it was impossible to distinguish K. gyiorum from other members of the Alcaligenaceae family. The VITEK 2 system must also be considered unreliable for the correct identification of K. gyiorum . Additionally, this study identified a candidate for an undescribed species of the genus Kerstersia. Discussion: MALDI-TOF MS is well suited for expanding the reference collection directly from routine diagnostics. The results of 16S gene sequencing should be interpreted with caution. Conversely, biochemical methods must be regarded as unreliable. The species’ large core genome suggests a specialized previously unknown specialized ecological niche. Furthermore, two distinct clusters within the reference collection suggest a common origin. Additionally, follow-up studies must determine whether one isolate that cannot be unambiguously assigned to a species represents a previously undescribed member of the genus Kerstersia.
- 5 October 2026
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 17, 1901541
Open AccessComparison of three routine methods for the identification of Kerstersia gyiorum from routine diagnostics and review of the literature
Introduction: Since its first description in 2003, clinical case reports have repeatedly documented that the bacterial species Kerstersia gyiorum is a human pathogen. K. gyiorum has been described in the context of wound and middle ear infections, has been found in urine samples, and has even been recognized as a causative agent of septicemia. However, the pathogenic potential of K. gyiorum cannot be clearly determined due to the current lack of information about this species. To reveal the clinical significance of K. gyiorum , it is therefore essential to first create a clearly defined reference collection of isolates obtained from routine clinical diagnostics. Methods: The aim of this study is to determine the most appropriate method for identifying K. gyiorum in routine diagnostics. To this end, three widely used routine methods (VITEK 2, MALDI-TOF MS, and 16S rRNA gene sequencing) were employed, and the accuracy of their results for K. gyiorum identification was compared. To ensure accurate species identification, dDDH (an NGS-based identification strategy) was used as the reference method. Furthermore, this manuscript provides an overview of all cases reported in the literature to date and discusses the accuracy of the identification results reported in these studies. In addition, genomic studies (pangenome and ANI matrix) were conducted using in silico analyses to investigate the clonal relationships among the isolates. Results: The results show that MALDI-TOF MS is best suited for identifying K. gyiorum in routine diagnostics. However, in contrast to most publications, 16S rRNA gene sequencing was not suitable, as it was impossible to distinguish K. gyiorum from other members of the Alcaligenaceae family. The VITEK 2 system must also be considered unreliable for the correct identification of K. gyiorum . Additionally, this study identified a candidate for an undescribed species of the genus Kerstersia. Discussion: MALDI-TOF MS is well suited for expanding the reference collection directly from routine diagnostics. The results of 16S gene sequencing should be interpreted with caution. Conversely, biochemical methods must be regarded as unreliable. The species’ large core genome suggests a specialized previously unknown specialized ecological niche. Furthermore, two distinct clusters within the reference collection suggest a common origin. Additionally, follow-up studies must determine whether one isolate that cannot be unambiguously assigned to a species represents a previously undescribed member of the genus Kerstersia.
- Open Access
- 24 July 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1645251
Editorial: Synergistic approaches to managing Gram-negative bacterial resistance
Multiresistant Gram-negative bacterial pathogens pose a major threat to global health (1, 2), and the continuous increase in antimicrobial resistance, coupled with the very limited introduction of new antibiotics, exacerbates this situation (3). One effective way to counteract antimicrobial resistance is through containment measures that can be implemented at local, regional and international levels. However, such measures require the collection of epidemiological data to deduce appropriate strategies, which can be very time consuming. In addition to the development of new antimicrobial drugs, ongoing evaluation of further treatment strategies is crucial. Notably, phage therapy has re-gained importance in recent decades (4), however, to successfully implement such alternatives, detailed knowledge of bacterial pathogenicity is essential. This includes genomic data, as well as knowledge regarding how pathogenic species interact with the host microbiome and immune system. This special edition highlights current research in this field and emphasises the threat of antibiotic resistance to public health. A major focus of this issue was placed on Klebsiella pneumoniae. In this context, epidemiological data were collected on the distribution of various resistance genes, and fundamental research contributing to a better understanding of pathogenicity was presented (5-7). Of particular note, regarding the genetics of hypervirulent K. pneumoniae, Yan et al. demonstrated the importance of the iucA gene for the expression of the hypervirulent pathotype (8). Additionally, Klapper et al. proposed the existence of three K. pneumoniae pathovars (classical K. pneumoniae, ESBL-positive, and hypervirulent K. pneumoniae). Their research revealed that hypervirulent strains evade phagocytosis by macrophages and exhibit cytotoxic potential (9). Further studies in this special issue investigated risk factors for infection with Acinetobacter baumanii in pediatric patients, as well as patients critically ill with COVID-19 (10, 11). An epidemiological study reported on patients in Lithuania who experienced invasive infection caused by Neisseria meningitidis (11). Moreover, a new resistance mechanism to fosfomycin in Morganella morganii was identified and a new human pathogenic species of the genus Stenotrophomoas was introduced into the taxonomy (12, 13). The findings presented in this special edition highlight critical areas for research, hospital hygiene and public health initiatives, indicating which isolates and pathovars should become a primary focus in the future.
- 24 July 2025
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 15, 1645251
Open AccessEditorial: Synergistic approaches to managing Gram-negative bacterial resistance
Multiresistant Gram-negative bacterial pathogens pose a major threat to global health (1, 2), and the continuous increase in antimicrobial resistance, coupled with the very limited introduction of new antibiotics, exacerbates this situation (3). One effective way to counteract antimicrobial resistance is through containment measures that can be implemented at local, regional and international levels. However, such measures require the collection of epidemiological data to deduce appropriate strategies, which can be very time consuming. In addition to the development of new antimicrobial drugs, ongoing evaluation of further treatment strategies is crucial. Notably, phage therapy has re-gained importance in recent decades (4), however, to successfully implement such alternatives, detailed knowledge of bacterial pathogenicity is essential. This includes genomic data, as well as knowledge regarding how pathogenic species interact with the host microbiome and immune system. This special edition highlights current research in this field and emphasises the threat of antibiotic resistance to public health. A major focus of this issue was placed on Klebsiella pneumoniae. In this context, epidemiological data were collected on the distribution of various resistance genes, and fundamental research contributing to a better understanding of pathogenicity was presented (5-7). Of particular note, regarding the genetics of hypervirulent K. pneumoniae, Yan et al. demonstrated the importance of the iucA gene for the expression of the hypervirulent pathotype (8). Additionally, Klapper et al. proposed the existence of three K. pneumoniae pathovars (classical K. pneumoniae, ESBL-positive, and hypervirulent K. pneumoniae). Their research revealed that hypervirulent strains evade phagocytosis by macrophages and exhibit cytotoxic potential (9). Further studies in this special issue investigated risk factors for infection with Acinetobacter baumanii in pediatric patients, as well as patients critically ill with COVID-19 (10, 11). An epidemiological study reported on patients in Lithuania who experienced invasive infection caused by Neisseria meningitidis (11). Moreover, a new resistance mechanism to fosfomycin in Morganella morganii was identified and a new human pathogenic species of the genus Stenotrophomoas was introduced into the taxonomy (12, 13). The findings presented in this special edition highlight critical areas for research, hospital hygiene and public health initiatives, indicating which isolates and pathovars should become a primary focus in the future.
- Open Access
Rapid Detection of Panton–Valentine Leukocidin Production in Clinical Isolates of Staphylococcus aureus from Saxony and Brandenburg and Their Molecular Characterisation
Panton–Valentine leukocidin (PVL) is a staphylococcal toxin associated with chronic/recurrent skin and soft tissue infections (SSTIs) and necrotizing pneumonia. Its detection in clinical isolates of Staphylococcus aureus warrants aggressive therapy and infection control measures. However, PVL detection relies on molecular methods of limited use, especially in outpatient or resource-poor settings. In order to aid the development of a lateral flow (LF) test for PVL, clinical isolates from SSTIs were collected in 2020/21 at three laboratories in two cities in the Eastern part of Germany. After the exclusion of duplicate and serial isolates, 83 isolates were eligible. These were tested using an experimental LF test for PVL production. They were also characterized using DNA microarrays, facilitating the detection of virulence and resistance markers as well as the assignment to clonal complexes and epidemic/pandemic strains. Thirty-nine isolates (47%) were PVL-positive, and the LF results were in 81 cases (97.6%) concordant with genotyping. One false-positive and one false-negative case were observed. This translated into a diagnostic sensitivity of 0.974 and a diagnostic specificity of 0.977. The most common PVL-positive MSSA lineages were CC152 (n = 6), CC121 (n = 4), and CC5 and CC30 (each n = 2). Thirty isolates (36%) were mecA-positive. The MRSA rate among PVL-negatives was 20% (nine isolates), but among the PVL-positives, it was as high as 54% (n = 21). The most common PVL-MRSA strains were CC398-MRSA-VT (n = 5), CC5-MRSA-IV “Sri Lanka Clone” (n = 4), CC8-MRSA-[mec IV+Hg] “Latin American USA300” (n = 4), and CC22-MRSA-IV (PVL+/tst+) (n = 2). While the PVL rate was similar just like the German isolates from a previous study a decade before, the MRSA rate among PVL-positives was clearly higher. All PVL-MRSA strains detected, as well as the most common methicillin-susceptible lineage (CC152), are known to be common locally in other parts of the world, and might, thus, be regarded as travel-associated. Therefore, patients with suspected PVL-associated disease should be asked for their history of travel or migration, and, in case of hospitalization, they should be treated as MRSA cases until proven otherwise.
Open AccessRapid Detection of Panton–Valentine Leukocidin Production in Clinical Isolates of Staphylococcus aureus from Saxony and Brandenburg and Their Molecular Characterisation
Panton–Valentine leukocidin (PVL) is a staphylococcal toxin associated with chronic/recurrent skin and soft tissue infections (SSTIs) and necrotizing pneumonia. Its detection in clinical isolates of Staphylococcus aureus warrants aggressive therapy and infection control measures. However, PVL detection relies on molecular methods of limited use, especially in outpatient or resource-poor settings. In order to aid the development of a lateral flow (LF) test for PVL, clinical isolates from SSTIs were collected in 2020/21 at three laboratories in two cities in the Eastern part of Germany. After the exclusion of duplicate and serial isolates, 83 isolates were eligible. These were tested using an experimental LF test for PVL production. They were also characterized using DNA microarrays, facilitating the detection of virulence and resistance markers as well as the assignment to clonal complexes and epidemic/pandemic strains. Thirty-nine isolates (47%) were PVL-positive, and the LF results were in 81 cases (97.6%) concordant with genotyping. One false-positive and one false-negative case were observed. This translated into a diagnostic sensitivity of 0.974 and a diagnostic specificity of 0.977. The most common PVL-positive MSSA lineages were CC152 (n = 6), CC121 (n = 4), and CC5 and CC30 (each n = 2). Thirty isolates (36%) were mecA-positive. The MRSA rate among PVL-negatives was 20% (nine isolates), but among the PVL-positives, it was as high as 54% (n = 21). The most common PVL-MRSA strains were CC398-MRSA-VT (n = 5), CC5-MRSA-IV “Sri Lanka Clone” (n = 4), CC8-MRSA-[mec IV+Hg] “Latin American USA300” (n = 4), and CC22-MRSA-IV (PVL+/tst+) (n = 2). While the PVL rate was similar just like the German isolates from a previous study a decade before, the MRSA rate among PVL-positives was clearly higher. All PVL-MRSA strains detected, as well as the most common methicillin-susceptible lineage (CC152), are known to be common locally in other parts of the world, and might, thus, be regarded as travel-associated. Therefore, patients with suspected PVL-associated disease should be asked for their history of travel or migration, and, in case of hospitalization, they should be treated as MRSA cases until proven otherwise.
- Open Access
- 13 November 2024
- Published by Springer Nature in BMC Microbiology
- Vol. 24 (1) , 1-15
Current knowledge on Inquilinus limosus, a scarcely researched human pathogen
Inquilinus limosus belongs to the class of the Alphaproteobacteria and was first described in 2002. So far, the species has mainly been isolated from respiratory specimens of patients with cystic fibrosis. A main characteristic of Inquilinus limosus is the prolonged time until bacterial colony growth is detectable. As the defined incubation times in many laboratories are too short to detect the growth of Inquilinus limosus, it is likely that the species is less frequently detected in the clinical setting than it actually occurs. This also explains why there are currently only very few data on the incidence available. Furthermore, as an uncommon pathogen, Inquilinus limosus may be familiar to only a few specialised clinicians. Due to these reasons, only little research (e.g. case reports and research papers) have been published on this species to date. However, given that a clear human pathogenic significance can be deduced from the existing literature, we have decided to present the current state of knowledge in this review and to address further aspects for the future elucidation of the pathogenesis of Inquilinus limosus.
- 13 November 2024
- Published by Springer Nature in BMC Microbiology
- Vol. 24 (1) , 1-15
Open AccessCurrent knowledge on Inquilinus limosus, a scarcely researched human pathogen
Inquilinus limosus belongs to the class of the Alphaproteobacteria and was first described in 2002. So far, the species has mainly been isolated from respiratory specimens of patients with cystic fibrosis. A main characteristic of Inquilinus limosus is the prolonged time until bacterial colony growth is detectable. As the defined incubation times in many laboratories are too short to detect the growth of Inquilinus limosus, it is likely that the species is less frequently detected in the clinical setting than it actually occurs. This also explains why there are currently only very few data on the incidence available. Furthermore, as an uncommon pathogen, Inquilinus limosus may be familiar to only a few specialised clinicians. Due to these reasons, only little research (e.g. case reports and research papers) have been published on this species to date. However, given that a clear human pathogenic significance can be deduced from the existing literature, we have decided to present the current state of knowledge in this review and to address further aspects for the future elucidation of the pathogenesis of Inquilinus limosus.
- Open Access
- 12 January 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (1) , 149
Enterococci, Van Gene-Carrying Enterococci, and Vancomycin Concentrations in the Influent of a Wastewater Treatment Plant in Southeast Germany
Vancomycin-resistant (VR) Enterococcus spp. can be detected in high concentrations in wastewaters and pose a risk to public health. During a one-year study (September 2022–August 2023), 24 h composite raw wastewater samples (n = 192) of a municipal wastewater treatment plant were investigated for cultivable enterococci. After growth on Slanetz–Bartley agar (SBA), a mean concentration of 29,736 ± 9919 cfu/mL was calculated. Using MALDI-TOF MS to characterize randomly picked colonies (n = 576), the most common species were found to be Enterococcus faecium (72.6%), E. hirae (13.7%), and E. faecalis (8.0%). Parallel incubation of wastewater samples on SBA and VRESelect agar resulted in a mean rate of VR enterococci of 2.0 ± 1.5%. All the tested strains grown on the VRESelect agar (n = 172) were E. faecium and carried the vanA (54.6%) or vanB gene (45.4%) with limited sequence differences. In susceptibility experiments, these isolates showed a high-level resistance to vancomycin (>256 µg/mL). Concentration of vancomycin was determined in 93.7% of 112 wastewater samples (mean: 123.1 ± 64.0 ng/L) and varied between below 100 ng/L (the detection limit) and 246.6 ng/L. A correlation between the concentration of vancomycin and the rate of VR strains among the total enterococci could not be found. The combination of incubation of samples on SBA and a commercial vancomycin-containing agar applied in clinical microbiology with a multiplex PCR for detection of van genes is an easy-to-use tool to quantify and characterize VR Enterococcus spp. in water samples.
- 12 January 2024
- Published by MDPI AG in Microorganisms
- Vol. 12 (1) , 149
Open AccessEnterococci, Van Gene-Carrying Enterococci, and Vancomycin Concentrations in the Influent of a Wastewater Treatment Plant in Southeast Germany
Vancomycin-resistant (VR) Enterococcus spp. can be detected in high concentrations in wastewaters and pose a risk to public health. During a one-year study (September 2022–August 2023), 24 h composite raw wastewater samples (n = 192) of a municipal wastewater treatment plant were investigated for cultivable enterococci. After growth on Slanetz–Bartley agar (SBA), a mean concentration of 29,736 ± 9919 cfu/mL was calculated. Using MALDI-TOF MS to characterize randomly picked colonies (n = 576), the most common species were found to be Enterococcus faecium (72.6%), E. hirae (13.7%), and E. faecalis (8.0%). Parallel incubation of wastewater samples on SBA and VRESelect agar resulted in a mean rate of VR enterococci of 2.0 ± 1.5%. All the tested strains grown on the VRESelect agar (n = 172) were E. faecium and carried the vanA (54.6%) or vanB gene (45.4%) with limited sequence differences. In susceptibility experiments, these isolates showed a high-level resistance to vancomycin (>256 µg/mL). Concentration of vancomycin was determined in 93.7% of 112 wastewater samples (mean: 123.1 ± 64.0 ng/L) and varied between below 100 ng/L (the detection limit) and 246.6 ng/L. A correlation between the concentration of vancomycin and the rate of VR strains among the total enterococci could not be found. The combination of incubation of samples on SBA and a commercial vancomycin-containing agar applied in clinical microbiology with a multiplex PCR for detection of van genes is an easy-to-use tool to quantify and characterize VR Enterococcus spp. in water samples.
- Open Access
- 3 January 2024
- Published by Springer Nature in BMC Microbiology
- Vol. 24 (1) , 1-18
The zoonotic pathogen Wohlfahrtiimonas chitiniclastica – current findings from a clinical and genomic perspective
The zoonotic pathogen Wohlfahrtiimonas chitiniclastica can cause several diseases in humans, including sepsis and bacteremia. Although the pathogenesis is not fully understood, the bacterium is thought to enter traumatic skin lesions via fly larvae, resulting in severe myiasis and/or wound contamination. Infections are typically associated with, but not limited to, infestation of an open wound by fly larvae, poor sanitary conditions, cardiovascular disease, substance abuse, and osteomyelitis. W. chitiniclastica is generally sensitive to a broad spectrum of antibiotics with the exception of fosfomycin. However, increasing drug resistance has been observed and its development should be monitored with caution. In this review, we summarize the currently available knowledge and evaluate it from both a clinical and a genomic perspective.
- 3 January 2024
- Published by Springer Nature in BMC Microbiology
- Vol. 24 (1) , 1-18
Open AccessThe zoonotic pathogen Wohlfahrtiimonas chitiniclastica – current findings from a clinical and genomic perspective
The zoonotic pathogen Wohlfahrtiimonas chitiniclastica can cause several diseases in humans, including sepsis and bacteremia. Although the pathogenesis is not fully understood, the bacterium is thought to enter traumatic skin lesions via fly larvae, resulting in severe myiasis and/or wound contamination. Infections are typically associated with, but not limited to, infestation of an open wound by fly larvae, poor sanitary conditions, cardiovascular disease, substance abuse, and osteomyelitis. W. chitiniclastica is generally sensitive to a broad spectrum of antibiotics with the exception of fosfomycin. However, increasing drug resistance has been observed and its development should be monitored with caution. In this review, we summarize the currently available knowledge and evaluate it from both a clinical and a genomic perspective.
- Open Access
- 3 July 2023
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 13, 1212627
Editorial: Characterization of rare and recently first described human pathogenic bacteria
Editorial: Characterization of rare and recently first described human pathogenic bacteria
- 3 July 2023
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 13, 1212627
Open AccessEditorial: Characterization of rare and recently first described human pathogenic bacteria
Editorial: Characterization of rare and recently first described human pathogenic bacteria
- Open Access
- 31 August 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (9) , 1767
Comparative Study of Different Diagnostic Routine Methods for the Identification of Acinetobacter radioresistens
Recent publications indicate that A. radioresistens can cause infections in humans, even though it is rarely reported in routine diagnostics. However, the fact that it is infrequently detected may be explained by the misidentification of the species by conventional methods. It is also likely that A. radioresistens is not considered clinically relevant and therefore not consistently included in diagnostic results. To elucidate the medical significance of this probably clinically underestimated bacterial species, we created a well-documented reference strain collection of 21 strains collected in routine diagnostics. For further analysis of A. radioresistens, it is essential to know which methods can be used to achieve a trustworthy identification. We, therefore, compared three methods widely used in routine diagnostics (MALDI-TOF MS, VITEK 2, and sequencing of housekeeping genes) in terms of secure and reliable identification of A. radioresistens. As reference methods, whole genome-based approaches were applied. VITEK 2 led to misidentification for four strains. However, MALDI-TOF MS and sequencing of housekeeping genes led to reliable and robust identifications.
- 31 August 2022
- Published by MDPI AG in Microorganisms
- Vol. 10 (9) , 1767
Open AccessComparative Study of Different Diagnostic Routine Methods for the Identification of Acinetobacter radioresistens
Recent publications indicate that A. radioresistens can cause infections in humans, even though it is rarely reported in routine diagnostics. However, the fact that it is infrequently detected may be explained by the misidentification of the species by conventional methods. It is also likely that A. radioresistens is not considered clinically relevant and therefore not consistently included in diagnostic results. To elucidate the medical significance of this probably clinically underestimated bacterial species, we created a well-documented reference strain collection of 21 strains collected in routine diagnostics. For further analysis of A. radioresistens, it is essential to know which methods can be used to achieve a trustworthy identification. We, therefore, compared three methods widely used in routine diagnostics (MALDI-TOF MS, VITEK 2, and sequencing of housekeeping genes) in terms of secure and reliable identification of A. radioresistens. As reference methods, whole genome-based approaches were applied. VITEK 2 led to misidentification for four strains. However, MALDI-TOF MS and sequencing of housekeeping genes led to reliable and robust identifications.
- Open Access
- 7 July 2022
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 912427
Comparative Genomic Analysis of the Human Pathogen Wohlfahrtiimonas Chitiniclastica Provides Insight Into the Identification of Antimicrobial Resistance Genotypes and Potential Virulence Traits
Recent studies suggest that Wohlfahrtiimonas chitiniclastica may be the cause of several diseases in humans including sepsis and bacteremia making the bacterium as a previously underappreciated human pathogen. However, very little is known about the pathogenicity and genetic potential of W. chitiniclastica; therefore, it is necessary to conduct systematic studies to gain a deeper understanding of its virulence characteristics and treatment options. In this study, the entire genetic repertoire of all publicly available W. chitiniclastica genomes was examined including in silico characterization of bacteriophage content, antibiotic resistome, and putative virulence profile. The pan-genome of W. chitiniclastica comprises 3819 genes with 1622 core genes (43%) indicating a putative metabolic conserved species. Furthermore, in silico analysis indicated presumed resistome expansion as defined by the presence of genome-encoded transposons and bacteriophages. While macrolide resistance genes macA and macB are located within the core genome, additional antimicrobial resistance genotypes for tetracycline (tetH, tetB, and tetD), aminoglycosides (ant(2’’)-Ia, aac(6’)-Ia,aph(3’’)-Ib, aph(3’)-Ia, and aph(6)-Id)), sulfonamide (sul2), streptomycin (strA), chloramphenicol (cat3), and beta-lactamase (blaVEB) are distributed among the accessory genome. Notably, our data indicate that the type strain DSM 18708T does not encode any additional clinically relevant antibiotic resistance genes, whereas drug resistance is increasing within the W. chitiniclastica clade. This trend should be monitored with caution. To the best of our knowledge, this is the first comprehensive genome analysis of this species, providing new insights into the genome of this opportunistic human pathogen.
- 7 July 2022
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 12, 912427
Open AccessComparative Genomic Analysis of the Human Pathogen Wohlfahrtiimonas Chitiniclastica Provides Insight Into the Identification of Antimicrobial Resistance Genotypes and Potential Virulence Traits
Recent studies suggest that Wohlfahrtiimonas chitiniclastica may be the cause of several diseases in humans including sepsis and bacteremia making the bacterium as a previously underappreciated human pathogen. However, very little is known about the pathogenicity and genetic potential of W. chitiniclastica; therefore, it is necessary to conduct systematic studies to gain a deeper understanding of its virulence characteristics and treatment options. In this study, the entire genetic repertoire of all publicly available W. chitiniclastica genomes was examined including in silico characterization of bacteriophage content, antibiotic resistome, and putative virulence profile. The pan-genome of W. chitiniclastica comprises 3819 genes with 1622 core genes (43%) indicating a putative metabolic conserved species. Furthermore, in silico analysis indicated presumed resistome expansion as defined by the presence of genome-encoded transposons and bacteriophages. While macrolide resistance genes macA and macB are located within the core genome, additional antimicrobial resistance genotypes for tetracycline (tetH, tetB, and tetD), aminoglycosides (ant(2’’)-Ia, aac(6’)-Ia,aph(3’’)-Ib, aph(3’)-Ia, and aph(6)-Id)), sulfonamide (sul2), streptomycin (strA), chloramphenicol (cat3), and beta-lactamase (blaVEB) are distributed among the accessory genome. Notably, our data indicate that the type strain DSM 18708T does not encode any additional clinically relevant antibiotic resistance genes, whereas drug resistance is increasing within the W. chitiniclastica clade. This trend should be monitored with caution. To the best of our knowledge, this is the first comprehensive genome analysis of this species, providing new insights into the genome of this opportunistic human pathogen.
- Open Access
- 22 September 2021
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 12
Identification and Antibiotic Profiling of Wohlfahrtiimonas chitiniclastica, an Underestimated Human Pathogen
In the past 12 years, several case reports have clearly demonstrated that Wohlfahrtiimonas chitiniclastica is capable of causing sepsis and bacteremia in humans. However, since most clinicians are not familiar with this species, little is known about its pathogenicity and treatment options while it is as rare but underestimated human pathogen. Therefore, a larger strain collection is required so that methods can be identified that are most suitable to obtain rapid and reliable identification. Moreover, the antimicrobial resistance profile needs to be elucidated in order to explore possible treatment options. Over a period of 6 years, we therefore have collected a total of 14 W. chitiniclastica isolates in routine diagnostics, which now served as the basis for a comprehensive characterization with respect to identification and antibiotic profiling. We compared the accuracy and convenience of several identification techniques in which MALDI-TOF MS and sequencing of the 16S rRNA gene have proven to be suitable for identification of W. chitiniclastica. In addition, whole genome sequencing (WGS)-based digital DNA-DNA hybridization (dDDH) was used as a reference method for strain identification, and surprised with the detection of a novel W. chitiniclastica subspecies. A combination of in silico and in vitro analyses revealed a first insight into the antimicrobial resistance profile and the molecular basis of antimicrobial resistance. Based on our findings, trimethoprim/sulfamethoxazole, levofloxacin, and cephalosporins (e.g., ceftazidime) may be the best antibiotics to use in order to treat infections caused by W. chitiniclastica, while resistance to fosfomycin, amikacin and tobramycin is observed.
- 22 September 2021
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 12
Open AccessIdentification and Antibiotic Profiling of Wohlfahrtiimonas chitiniclastica, an Underestimated Human Pathogen
In the past 12 years, several case reports have clearly demonstrated that Wohlfahrtiimonas chitiniclastica is capable of causing sepsis and bacteremia in humans. However, since most clinicians are not familiar with this species, little is known about its pathogenicity and treatment options while it is as rare but underestimated human pathogen. Therefore, a larger strain collection is required so that methods can be identified that are most suitable to obtain rapid and reliable identification. Moreover, the antimicrobial resistance profile needs to be elucidated in order to explore possible treatment options. Over a period of 6 years, we therefore have collected a total of 14 W. chitiniclastica isolates in routine diagnostics, which now served as the basis for a comprehensive characterization with respect to identification and antibiotic profiling. We compared the accuracy and convenience of several identification techniques in which MALDI-TOF MS and sequencing of the 16S rRNA gene have proven to be suitable for identification of W. chitiniclastica. In addition, whole genome sequencing (WGS)-based digital DNA-DNA hybridization (dDDH) was used as a reference method for strain identification, and surprised with the detection of a novel W. chitiniclastica subspecies. A combination of in silico and in vitro analyses revealed a first insight into the antimicrobial resistance profile and the molecular basis of antimicrobial resistance. Based on our findings, trimethoprim/sulfamethoxazole, levofloxacin, and cephalosporins (e.g., ceftazidime) may be the best antibiotics to use in order to treat infections caused by W. chitiniclastica, while resistance to fosfomycin, amikacin and tobramycin is observed.